1 Study Coverage 1.1 Pneumonia Vaccine Product Introduction 1.2 Global Pneumonia Vaccine Outlook 2017 VS 2022 VS 2028 1.2.1 Global Pneumonia Vaccine Sales in US$ Million for the Year 2017-2028 1.2.2 Global Pneumonia Vaccine Sales in Volume for the Year 2017-2028 1.3 United States Pneumonia Vaccine Outlook 2017 VS 2022 VS 2028 1.3.1 United States Pneumonia Vaccine Sales in US$ Million for the Year 2017-2028 1.3.2 United States Pneumonia Vaccine Sales in Volume for the Year 2017-2028 1.4 Pneumonia Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Pneumonia Vaccine in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Pneumonia Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Pneumonia Vaccine Market Dynamics 1.5.1 Pneumonia Vaccine Industry Trends 1.5.2 Pneumonia Vaccine Market Drivers 1.5.3 Pneumonia Vaccine Market Challenges 1.5.4 Pneumonia Vaccine Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Pneumonia Vaccine Market Segment by Type 2.1.1 Pneumococcal Conjugate Vaccine (PCV13) 2.1.2 Pneumococcal Polysaccharide Vaccine (PPSV23) 2.1.3 Other 2.2 Global Pneumonia Vaccine Market Size by Type 2.2.1 Global Pneumonia Vaccine Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Pneumonia Vaccine Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Pneumonia Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Pneumonia Vaccine Market Size by Type 2.3.1 United States Pneumonia Vaccine Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Pneumonia Vaccine Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Pneumonia Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Pneumonia Vaccine Market Segment by Application 3.1.1 Pneumonia 3.1.2 Meningitis 3.1.3 Sepsis 3.2 Global Pneumonia Vaccine Market Size by Application 3.2.1 Global Pneumonia Vaccine Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Pneumonia Vaccine Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Pneumonia Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Pneumonia Vaccine Market Size by Application 3.3.1 United States Pneumonia Vaccine Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Pneumonia Vaccine Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Pneumonia Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Pneumonia Vaccine Competitor Landscape by Company 4.1 Global Pneumonia Vaccine Market Size by Company 4.1.1 Top Global Pneumonia Vaccine Manufacturers Ranked by Revenue (2021) 4.1.2 Global Pneumonia Vaccine Revenue by Manufacturer (2017-2022) 4.1.3 Global Pneumonia Vaccine Sales by Manufacturer (2017-2022) 4.1.4 Global Pneumonia Vaccine Price by Manufacturer (2017-2022) 4.2 Global Pneumonia Vaccine Concentration Ratio (CR) 4.2.1 Pneumonia Vaccine Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Pneumonia Vaccine in 2021 4.2.3 Global Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Pneumonia Vaccine Manufacturing Base Distribution, Product Type 4.3.1 Global Pneumonia Vaccine Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Pneumonia Vaccine Product Type 4.3.3 Date of International Manufacturers Enter into Pneumonia Vaccine Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Pneumonia Vaccine Market Size by Company 4.5.1 Top Pneumonia Vaccine Players in United States, Ranked by Revenue (2021) 4.5.2 United States Pneumonia Vaccine Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Pneumonia Vaccine Sales by Players (2020, 2021 & 2022) 5 Global Pneumonia Vaccine Market Size by Region 5.1 Global Pneumonia Vaccine Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Pneumonia Vaccine Market Size in Volume by Region (2017-2028) 5.2.1 Global Pneumonia Vaccine Sales in Volume by Region: 2017-2022 5.2.2 Global Pneumonia Vaccine Sales in Volume Forecast by Region (2023-2028) 5.3 Global Pneumonia Vaccine Market Size in Value by Region (2017-2028) 5.3.1 Global Pneumonia Vaccine Sales in Value by Region: 2017-2022 5.3.2 Global Pneumonia Vaccine Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Pneumonia Vaccine Market Size YoY Growth 2017-2028 6.1.2 North America Pneumonia Vaccine Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Pneumonia Vaccine Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Pneumonia Vaccine Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Pneumonia Vaccine Market Size YoY Growth 2017-2028 6.3.2 Europe Pneumonia Vaccine Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Pneumonia Vaccine Market Size YoY Growth 2017-2028 6.4.2 Latin America Pneumonia Vaccine Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Pneumonia Vaccine Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Pneumonia Vaccine Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Pfizer Inc. 7.1.1 Pfizer Inc. Corporation Information 7.1.2 Pfizer Inc. Description and Business Overview 7.1.3 Pfizer Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Pfizer Inc. Pneumonia Vaccine Products Offered 7.1.5 Pfizer Inc. Recent Development 7.2 Glaxosmithkline Plc. 7.2.1 Glaxosmithkline Plc. Corporation Information 7.2.2 Glaxosmithkline Plc. Description and Business Overview 7.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Glaxosmithkline Plc. Pneumonia Vaccine Products Offered 7.2.5 Glaxosmithkline Plc. Recent Development 7.3 Merck & Co., Inc. 7.3.1 Merck & Co., Inc. Corporation Information 7.3.2 Merck & Co., Inc. Description and Business Overview 7.3.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Merck & Co., Inc. Pneumonia Vaccine Products Offered 7.3.5 Merck & Co., Inc. Recent Development 7.4 Sanofi Pasteur 7.4.1 Sanofi Pasteur Corporation Information 7.4.2 Sanofi Pasteur Description and Business Overview 7.4.3 Sanofi Pasteur Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Sanofi Pasteur Pneumonia Vaccine Products Offered 7.4.5 Sanofi Pasteur Recent Development 7.5 Serum Institute of India Pvt. Ltd. 7.5.1 Serum Institute of India Pvt. Ltd. Corporation Information 7.5.2 Serum Institute of India Pvt. Ltd. Description and Business Overview 7.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Products Offered 7.5.5 Serum Institute of India Pvt. Ltd. Recent Development 7.6 Johnson & Johnson 7.6.1 Johnson & Johnson Corporation Information 7.6.2 Johnson & Johnson Description and Business Overview 7.6.3 Johnson & Johnson Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Johnson & Johnson Pneumonia Vaccine Products Offered 7.6.5 Johnson & Johnson Recent Development 7.7 Astellas Pharma Inc. 7.7.1 Astellas Pharma Inc. Corporation Information 7.7.2 Astellas Pharma Inc. Description and Business Overview 7.7.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Astellas Pharma Inc. Pneumonia Vaccine Products Offered 7.7.5 Astellas Pharma Inc. Recent Development 7.8 Astrazeneca Plc. 7.8.1 Astrazeneca Plc. Corporation Information 7.8.2 Astrazeneca Plc. Description and Business Overview 7.8.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Astrazeneca Plc. Pneumonia Vaccine Products Offered 7.8.5 Astrazeneca Plc. Recent Development 7.9 CSL Limited 7.9.1 CSL Limited Corporation Information 7.9.2 CSL Limited Description and Business Overview 7.9.3 CSL Limited Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022) 7.9.4 CSL Limited Pneumonia Vaccine Products Offered 7.9.5 CSL Limited Recent Development 7.10 Emergent Biosolutions 7.10.1 Emergent Biosolutions Corporation Information 7.10.2 Emergent Biosolutions Description and Business Overview 7.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022) 7.10.4 Emergent Biosolutions Pneumonia Vaccine Products Offered 7.10.5 Emergent Biosolutions Recent Development 7.11 Walvax Biotechnology 7.11.1 Walvax Biotechnology Corporation Information 7.11.2 Walvax Biotechnology Description and Business Overview 7.11.3 Walvax Biotechnology Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022) 7.11.4 Walvax Biotechnology Pneumonia Vaccine Products Offered 7.11.5 Walvax Biotechnology Recent Development 7.12 Royal (Wuxi) Bio-Pharmaceutical 7.12.1 Royal (Wuxi) Bio-Pharmaceutical Corporation Information 7.12.2 Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview 7.12.3 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022) 7.12.4 Royal (Wuxi) Bio-Pharmaceutical Products Offered 7.12.5 Royal (Wuxi) Bio-Pharmaceutical Recent Development 7.13 Zhifei Biologic 7.13.1 Zhifei Biologic Corporation Information 7.13.2 Zhifei Biologic Description and Business Overview 7.13.3 Zhifei Biologic Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022) 7.13.4 Zhifei Biologic Products Offered 7.13.5 Zhifei Biologic Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Pneumonia Vaccine Industry Chain Analysis 8.2 Pneumonia Vaccine Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Pneumonia Vaccine Distributors 8.3 Pneumonia Vaccine Production Mode & Process 8.4 Pneumonia Vaccine Sales and Marketing 8.4.1 Pneumonia Vaccine Sales Channels 8.4.2 Pneumonia Vaccine Distributors 8.5 Pneumonia Vaccine Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Pneumonia Vaccine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Pneumonia Vaccine Market Trends Table 3. Pneumonia Vaccine Market Drivers Table 4. Pneumonia Vaccine Market Challenges Table 5. Pneumonia Vaccine Market Restraints Table 6. Global Pneumonia Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Pneumonia Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Pneumonia Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Pneumonia Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Pneumonia Vaccine Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Pneumonia Vaccine Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Pneumonia Vaccine Revenue Share by Manufacturer, 2017-2022 Table 13. Global Pneumonia Vaccine Sales by Manufacturer, (K Doses), 2017-2022 Table 14. Global Pneumonia Vaccine Sales Share by Manufacturer, 2017-2022 Table 15. Global Pneumonia Vaccine Price by Manufacturer (2017-2022) & (USD/Dose) Table 16. Global Pneumonia Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Pneumonia Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia Vaccine as of 2021) Table 18. Top Players of Pneumonia Vaccine in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Pneumonia Vaccine Product Type Table 20. Date of International Manufacturers Enter into Pneumonia Vaccine Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Pneumonia Vaccine Players in United States Market, Ranking by Revenue (2021) Table 23. United States Pneumonia Vaccine Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Pneumonia Vaccine Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Pneumonia Vaccine Sales by Players, (K Doses), 2020, 2021 & 2022 Table 26. United States Pneumonia Vaccine Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Pneumonia Vaccine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Pneumonia Vaccine Sales in Volume by Region (2017-2022) & (K Doses) Table 29. Global Pneumonia Vaccine Sales in Volume Forecast by Region (2023-2028) & (K Doses) Table 30. Global Pneumonia Vaccine Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Pneumonia Vaccine Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Pneumonia Vaccine Sales in Volume by Country (2017-2028) & (K Doses) Table 33. North America Pneumonia Vaccine Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Pneumonia Vaccine Sales in Volume by Region (2017-2028) & (K Doses) Table 35. Asia Pacific Pneumonia Vaccine Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Pneumonia Vaccine Sales in Volume by Country (2017-2028) & (K Doses) Table 37. Europe Pneumonia Vaccine Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Pneumonia Vaccine Sales in Volume by Country (2017-2028) & (K Doses) Table 39. Latin Americaa Pneumonia Vaccine Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Pneumonia Vaccine Sales in Volume by Country (2017-2028) & (K Doses) Table 41. Middle East and Africa Pneumonia Vaccine Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Pfizer Inc. Corporation Information Table 43. Pfizer Inc. Description and Business Overview Table 44. Pfizer Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 45. Pfizer Inc. Pneumonia Vaccine Product Table 46. Pfizer Inc. Recent Development Table 47. Glaxosmithkline Plc. Corporation Information Table 48. Glaxosmithkline Plc. Description and Business Overview Table 49. Glaxosmithkline Plc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 50. Glaxosmithkline Plc. Product Table 51. Glaxosmithkline Plc. Recent Development Table 52. Merck & Co., Inc. Corporation Information Table 53. Merck & Co., Inc. Description and Business Overview Table 54. Merck & Co., Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 55. Merck & Co., Inc. Product Table 56. Merck & Co., Inc. Recent Development Table 57. Sanofi Pasteur Corporation Information Table 58. Sanofi Pasteur Description and Business Overview Table 59. Sanofi Pasteur Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 60. Sanofi Pasteur Product Table 61. Sanofi Pasteur Recent Development Table 62. Serum Institute of India Pvt. Ltd. Corporation Information Table 63. Serum Institute of India Pvt. Ltd. Description and Business Overview Table 64. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 65. Serum Institute of India Pvt. Ltd. Product Table 66. Serum Institute of India Pvt. Ltd. Recent Development Table 67. Johnson & Johnson Corporation Information Table 68. Johnson & Johnson Description and Business Overview Table 69. Johnson & Johnson Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 70. Johnson & Johnson Product Table 71. Johnson & Johnson Recent Development Table 72. Astellas Pharma Inc. Corporation Information Table 73. Astellas Pharma Inc. Description and Business Overview Table 74. Astellas Pharma Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 75. Astellas Pharma Inc. Product Table 76. Astellas Pharma Inc. Recent Development Table 77. Astrazeneca Plc. Corporation Information Table 78. Astrazeneca Plc. Description and Business Overview Table 79. Astrazeneca Plc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 80. Astrazeneca Plc. Product Table 81. Astrazeneca Plc. Recent Development Table 82. CSL Limited Corporation Information Table 83. CSL Limited Description and Business Overview Table 84. CSL Limited Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 85. CSL Limited Product Table 86. CSL Limited Recent Development Table 87. Emergent Biosolutions Corporation Information Table 88. Emergent Biosolutions Description and Business Overview Table 89. Emergent Biosolutions Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 90. Emergent Biosolutions Product Table 91. Emergent Biosolutions Recent Development Table 92. Walvax Biotechnology Corporation Information Table 93. Walvax Biotechnology Description and Business Overview Table 94. Walvax Biotechnology Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 95. Walvax Biotechnology Product Table 96. Walvax Biotechnology Recent Development Table 97. Royal (Wuxi) Bio-Pharmaceutical Corporation Information Table 98. Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview Table 99. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 100. Royal (Wuxi) Bio-Pharmaceutical Product Table 101. Royal (Wuxi) Bio-Pharmaceutical Recent Development Table 102. Zhifei Biologic Corporation Information Table 103. Zhifei Biologic Description and Business Overview Table 104. Zhifei Biologic Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 105. Zhifei Biologic Product Table 106. Zhifei Biologic Recent Development Table 107. Key Raw Materials Lists Table 108. Raw Materials Key Suppliers Lists Table 109. Pneumonia Vaccine Customers List Table 110. Pneumonia Vaccine Distributors List Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Pneumonia Vaccine Product Picture Figure 2. Global Pneumonia Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Pneumonia Vaccine Market Size 2017-2028 (US$ Million) Figure 4. Global Pneumonia Vaccine Sales 2017-2028 (K Doses) Figure 5. United States Pneumonia Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Pneumonia Vaccine Market Size 2017-2028 (US$ Million) Figure 7. United States Pneumonia Vaccine Sales 2017-2028 (K Doses) Figure 8. United States Pneumonia Vaccine Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Pneumonia Vaccine Market Share in Global, in Volume (K Doses) 2017-2028 Figure 10. Pneumonia Vaccine Report Years Considered Figure 11. Product Picture of Pneumococcal Conjugate Vaccine (PCV13) Figure 12. Product Picture of Pneumococcal Polysaccharide Vaccine (PPSV23) Figure 13. Product Picture of Other Figure 14. Global Pneumonia Vaccine Market Share by Type in 2022 & 2028 Figure 15. Global Pneumonia Vaccine Sales in Value by Type (2017-2028) & (US$ Million) Figure 16. Global Pneumonia Vaccine Sales Market Share in Value by Type (2017-2028) Figure 17. Global Pneumonia Vaccine Sales by Type (2017-2028) & (K Doses) Figure 18. Global Pneumonia Vaccine Sales Market Share in Volume by Type (2017-2028) Figure 19. Global Pneumonia Vaccine Price by Type (2017-2028) & (USD/Dose) Figure 20. United States Pneumonia Vaccine Market Share by Type in 2022 & 2028 Figure 21. United States Pneumonia Vaccine Sales in Value by Type (2017-2028) & (US$ Million) Figure 22. United States Pneumonia Vaccine Sales Market Share in Value by Type (2017-2028) Figure 23. United States Pneumonia Vaccine Sales by Type (2017-2028) & (K Doses) Figure 24. United States Pneumonia Vaccine Sales Market Share in Volume by Type (2017-2028) Figure 25. United States Pneumonia Vaccine Price by Type (2017-2028) & (USD/Dose) Figure 26. Product Picture of Pneumonia Figure 27. Product Picture of Meningitis Figure 28. Product Picture of Sepsis Figure 29. Global Pneumonia Vaccine Market Share by Application in 2022 & 2028 Figure 30. Global Pneumonia Vaccine Sales in Value by Application (2017-2028) & (US$ Million) Figure 31. Global Pneumonia Vaccine Sales Market Share in Value by Application (2017-2028) Figure 32. Global Pneumonia Vaccine Sales by Application (2017-2028) & (K Doses) Figure 33. Global Pneumonia Vaccine Sales Market Share in Volume by Application (2017-2028) Figure 34. Global Pneumonia Vaccine Price by Application (2017-2028) & (USD/Dose) Figure 35. United States Pneumonia Vaccine Market Share by Application in 2022 & 2028 Figure 36. United States Pneumonia Vaccine Sales in Value by Application (2017-2028) & (US$ Million) Figure 37. United States Pneumonia Vaccine Sales Market Share in Value by Application (2017-2028) Figure 38. United States Pneumonia Vaccine Sales by Application (2017-2028) & (K Doses) Figure 39. United States Pneumonia Vaccine Sales Market Share in Volume by Application (2017-2028) Figure 40. United States Pneumonia Vaccine Price by Application (2017-2028) & (USD/Dose) Figure 41. North America Pneumonia Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses) Figure 42. North America Pneumonia Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 43. U.S. Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Canada Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 45. Europe Pneumonia Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses) Figure 46. Europe Pneumonia Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 47. Germany Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. France Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. U.K. Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Italy Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Russia Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Asia-Pacific Pneumonia Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses) Figure 53. Asia-Pacific Pneumonia Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 54. China Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. Japan Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. South Korea Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. India Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Australia Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Taiwan Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Indonesia Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Thailand Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Malaysia Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Philippines Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Latin America Pneumonia Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses) Figure 65. Latin America Pneumonia Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 66. Mexico Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Brazil Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Argentina Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Middle East & Africa Pneumonia Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses) Figure 70. Middle East & Africa Pneumonia Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 71. Turkey Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Saudi Arabia Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. U.A.E Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. Pneumonia Vaccine Value Chain Figure 75. Pneumonia Vaccine Production Process Figure 76. Channels of Distribution Figure 77. Distributors Profiles Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

Pfizer Inc. Glaxosmithkline Plc. Merck & Co., Inc. Sanofi Pasteur Serum Institute of India Pvt. Ltd. Johnson & Johnson Astellas Pharma Inc. Astrazeneca Plc. CSL Limited Emergent Biosolutions Walvax Biotechnology Royal (Wuxi) Bio-Pharmaceutical Zhifei Biologic